Answers are grounded in this paper and cite their sources.
Alzheimer's disease (AD) is marked by memory loss and cognitive decline, with neuronal hyperactivity linked to amyloid beta peptides (Aβs) that enhance sodium channels. Using patch-clamp techniques, we determined that the receptor for Aβ corresponds to the type I taste receptor (T1R2/T1R3). This discovery reveals Aβ's physiological roles and offers a new molecular target for developing therapies to inhibit or modify Aβ binding, potentially regulating neurohyperactivity in AD.
No takes yet. Share an insight, caveat, or question.
Saito et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: